{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:43:46Z","timestamp":1794887026891,"version":"4.9.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MFE-176478"],"award-info":[{"award-number":["MFE-176478"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143264"],"award-info":[{"award-number":["FDN-143264"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154288"],"award-info":[{"award-number":["FDN-154288"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19H05640"],"award-info":[{"award-number":["JP19H05640"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H06411"],"award-info":[{"award-number":["17H06411"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI073289"],"award-info":[{"award-number":["R01AI073289"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI116420"],"award-info":[{"award-number":["AI116420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI125770"],"award-info":[{"award-number":["AI125770"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 5R01AI135812"],"award-info":[{"award-number":["R01 5R01AI135812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fungal infections cause more than 1.5 million deaths annually. With an increase in immune-deficient susceptible populations and the emergence of antifungal drug resistance, there is an urgent need for novel strategies to combat these life-threatening infections. Here, we use a combinatorial screening approach to identify an imidazopyrazoindole, NPD827, that synergizes with fluconazole against azole-sensitive and -resistant isolates of <jats:italic>Candida albicans<\/jats:italic>. NPD827 interacts with sterols, resulting in profound effects on fungal membrane homeostasis and induction of membrane-associated stress responses. The compound impairs virulence in a <jats:italic>Caenorhabditis elegans<\/jats:italic> model of candidiasis, blocks <jats:italic>C. albicans<\/jats:italic> filamentation in vitro, and prevents biofilm formation in a rat model of catheter infection by <jats:italic>C. albicans<\/jats:italic>. Collectively, this work identifies an imidazopyrazoindole scaffold with a non-protein-targeted mode of action that re-sensitizes the leading human fungal pathogen, <jats:italic>C. albicans<\/jats:italic>, to azole antifungals.<\/jats:p>","DOI":"10.1038\/s41467-022-31308-1","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T06:03:19Z","timestamp":1656136999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation"],"prefix":"10.1038","volume":"13","author":[{"given":"Nicole M.","family":"Revie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kali R.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1493-490X","authenticated-orcid":false,"given":"Michelle E.","family":"Maxson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9487-7361","authenticated-orcid":false,"given":"Kirsten J.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Skulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0483-9626","authenticated-orcid":false,"given":"Meea","family":"Fogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-650X","authenticated-orcid":false,"given":"Hiram","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Yashiroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-5548","authenticated-orcid":false,"given":"Hiroyuki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4376-5674","authenticated-orcid":false,"given":"Minoru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3606-4925","authenticated-orcid":false,"given":"Hiroyuki","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-6760","authenticated-orcid":false,"given":"Charles","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-8865","authenticated-orcid":false,"given":"Rebecca S.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7927-9950","authenticated-orcid":false,"given":"David R.","family":"Andes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9129-7131","authenticated-orcid":false,"given":"Gerard D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7909-1803","authenticated-orcid":false,"given":"Justin R.","family":"Nodwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Del Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7963-7140","authenticated-orcid":false,"given":"Martin D.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-5766","authenticated-orcid":false,"given":"Luke","family":"Whitesell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-0110","authenticated-orcid":false,"given":"Leah E.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"31308_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 1\u201310 (2012).","journal-title":"Sci. Transl. Med."},{"key":"31308_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","volume":"45","author":"NM Revie","year":"2018","unstructured":"Revie, N. M., Iyer, K. R., Robbins, N. & Cowen, L. E. Antifungal drug resistance: evolution, mechanisms, and impact. Curr. Opin. Microbiol. 45, 70\u201376 (2018).","journal-title":"Curr. Opin. Microbiol."},{"key":"31308_CR3","first-page":"739","volume":"360","author":"MC Fisher","year":"2018","unstructured":"Fisher, M. C., Hawkins, N. J., Sanglard, D. & Gurr, S. J. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science (1979) 360, 739\u2013742 (2018).","journal-title":"Science (1979)"},{"key":"31308_CR4","first-page":"903","volume":"4","author":"N Robbins","year":"2016","unstructured":"Robbins, N., Wright, G. D. & Cowen, L. E. Antifungal drugs: the current armamentarium and development of new agents. Fungal Kingd. 4, 903\u2013922 (2016).","journal-title":"Fungal Kingd."},{"key":"31308_CR5","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States (U.S. Department of Health and Human Services, CDC, Atlanta, GA, 2019)."},{"key":"31308_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"T Roemer","year":"2014","unstructured":"Roemer, T. & Krysan, D. J. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb. Perspect. Med. 4, 1\u201314 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"31308_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1128\/MMBR.00045-10","volume":"75","author":"RS Shapiro","year":"2011","unstructured":"Shapiro, R. S., Robbins, N. & Cowen, L. E. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75, 213\u2013267 (2011).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"31308_CR8","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/AAC.04239-14","volume":"59","author":"A Luna-Tapia","year":"2015","unstructured":"Luna-Tapia, A., Kerns, M. E., Eberle, K. E., Jursic, B. S. & Palmer, G. E. Trafficking through the late endosome significantly impacts Candida albicans tolerance of the azole antifungals. Antimicrob. Agents Chemother. 59, 2410\u20132420 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR9","doi-asserted-by":"publisher","first-page":"39812","DOI":"10.1371\/journal.pone.0039812","volume":"7","author":"A Singh","year":"2012","unstructured":"Singh, A., Yadav, V. & Prasad, R. Comparative lipidomics in clinical isolates of Candida albicans reveal crosstalk between mitochondria, cell wall integrity and azole resistance. PLoS ONE 7, 39812 (2012).","journal-title":"PLoS ONE"},{"key":"31308_CR10","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1128\/AAC.48.5.1778-1787.2004","volume":"48","author":"K Mukhopadhyay","year":"2004","unstructured":"Mukhopadhyay, K. et al. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob. Agents Chemother. 48, 1778\u20131787 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1180823","volume":"327","author":"M Costanzo","year":"2010","unstructured":"Costanzo, M. et al. The genetic landscape of a cell. Science 327, 425\u2013431 (2010).","journal-title":"Science"},{"key":"31308_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cbpa.2003.12.007","volume":"8","author":"JR Sharom","year":"2004","unstructured":"Sharom, J. R., Bellows, D. S. & Tyers, M. From large networks to small molecules. Curr. Opin. Chem. Biol. 8, 81\u201390 (2004).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"31308_CR13","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.celrep.2015.10.018","volume":"13","author":"N Robbins","year":"2015","unstructured":"Robbins, N. et al. An antifungal combination matrix identifies a rich pool of adjuvant molecules that enhance drug activity against diverse fungal pathogens. Cell Rep. 13, 1481\u20131492 (2015).","journal-title":"Cell Rep."},{"key":"31308_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-018-0141-x","volume":"17","author":"M Tyers","year":"2019","unstructured":"Tyers, M. & Wright, G. D. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 17, 141\u2013155 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"31308_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/21505594.2016.1196300","volume":"8","author":"M Spitzer","year":"2017","unstructured":"Spitzer, M., Robbins, N. & Wright, G. D. Combinatorial strategies for combating invasive fungal infections. Virulence 8, 169\u2013185 (2017).","journal-title":"Virulence"},{"key":"31308_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann, G. R., Leh\u00e1r, J. & Keith, C. T. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 12, 34\u201342 (2007).","journal-title":"Drug Discov. Today"},{"key":"31308_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","volume":"19","author":"KR Iyer","year":"2021","unstructured":"Iyer, K. R., Revie, N. M., Fu, C., Robbins, N. & Cowen, L. E. Treatment strategies for cryptococcal infection: challenges, advances, and future outlook. Nat. Rev. Microbiol. 19, 454\u2013466 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"31308_CR18","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","volume":"368","author":"JN Day","year":"2013","unstructured":"Day, J. N. et al. Combination antifungal therapy for cryptococcal meningitis. N. Engl. J. Med. 368, 1291\u20131302 (2013).","journal-title":"N. Engl. J. Med."},{"key":"31308_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham, R. et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect. Dis. 17, 873\u2013881 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"31308_CR20","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","volume":"41","author":"TC White","year":"1997","unstructured":"White, T. C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate, with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 1482\u20131487 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0378-1119(91)90310-8","volume":"107","author":"A Jandrositz","year":"1991","unstructured":"Jandrositz, A., Turnowsky, F. & H\u00f6genauer, G. The gene encoding squalene epoxidase from Saccharomyces cerevisiae: cloning and characterization. Gene 107, 155\u2013160 (1991).","journal-title":"Gene"},{"key":"31308_CR22","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/AAC.34.6.989","volume":"34","author":"C Marcireau","year":"1990","unstructured":"Marcireau, C., Guilloton, M. & Karst, F. In vivo effects of fenpropimorph on the yeast Saccharomyces cerevisiae and determination of the molecular basis of the antifungal property. Antimicrob. Agents Chemother. 34, 989\u2013993 (1990).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nchembio.1496","volume":"10","author":"TM Anderson","year":"2014","unstructured":"Anderson, T. M. et al. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat. Chem. Biol. 10, 400\u2013406 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"31308_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2958.2003.03697.x","volume":"50","author":"T Roemer","year":"2003","unstructured":"Roemer, T. et al. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 50, 167\u2013181 (2003).","journal-title":"Mol. Microbiol."},{"key":"31308_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.plipres.2010.03.003","volume":"49","author":"S Gulati","year":"2010","unstructured":"Gulati, S., Liu, Y., Munkacsi, A. B., Wilcox, L. & Sturley, S. L. Sterols and sphingolipids: dynamic duo or partners in crime? Prog. Lipid Res. 49, 353\u2013365 (2010).","journal-title":"Prog. Lipid Res."},{"key":"31308_CR26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1091\/mbc.e08-11-1126","volume":"20","author":"XL Guan","year":"2009","unstructured":"Guan, X. L. et al. Functional interactions between sphingolipids and sterols in biological membranes regulating cell physiology. Mol. Biol. Cell 20, 2673\u20132683 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"31308_CR27","first-page":"435","volume":"92","author":"E Jarc","year":"2019","unstructured":"Jarc, E. & Petan, T. Lipid droplets and the management of cellular stress. Yale J. Biol. Med. 92, 435\u2013452 (2019).","journal-title":"Yale J. Biol. Med."},{"key":"31308_CR28","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1194\/jlr.R067595","volume":"57","author":"J Han","year":"2016","unstructured":"Han, J. & Kaufman, R. J. The role of ER stress in lipid metabolism and lipotoxicity. J. Lipid Res. 57, 1329\u20131338 (2016).","journal-title":"J. Lipid Res."},{"key":"31308_CR29","first-page":"1081","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter, P. & Ron, D. The unfolded protein response: From stress pathway to homeostatic regulation. Science (1979) 334, 1081\u20131087 (2011).","journal-title":"Science (1979)"},{"key":"31308_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann, J. A. & Carvalho, P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 20, 137\u2013155 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"31308_CR31","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.bbalip.2014.09.012","volume":"1841","author":"M Bosma","year":"2014","unstructured":"Bosma, M. et al. Sequestration of fatty acids in triglycerides prevents endoplasmic reticulum stress in an in vitro model of cardiomyocyte lipotoxicity. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids 1841, 1648\u20131655 (2014).","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"31308_CR32","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.fgb.2008.06.001","volume":"45","author":"TT Wimalasena","year":"2008","unstructured":"Wimalasena, T. T. et al. Impact of the unfolded protein response upon genome-wide expression patterns, and the role of Hac1 in the polarized growth, of Candida albicans. Fungal Genet. Biol. 45, 1235\u20131247 (2008).","journal-title":"Fungal Genet. Biol."},{"key":"31308_CR33","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1093\/emboj\/21.10.2343","volume":"21","author":"M Bonilla","year":"2002","unstructured":"Bonilla, M., Nastase, K. K. & Cunningham, K. W. Essential role of calcineurin in response to endoplasmic reticulum stress. EMBO J. 21, 2343\u20132353 (2002).","journal-title":"EMBO J."},{"key":"31308_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0143-4160(86)90026-6","volume":"7","author":"JW Putney","year":"1986","unstructured":"Putney, J. W. A model for receptor-regulated calcium entry. Cell Calcium 7, 1\u201312 (1986).","journal-title":"Cell Calcium"},{"key":"31308_CR35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0143-4160(90)90016-N","volume":"11","author":"JW Putney","year":"1990","unstructured":"Putney, J. W. Capacitative calcium entry revisited: Review article. Cell Calcium 11, 611\u2013624 (1990).","journal-title":"Cell Calcium"},{"key":"31308_CR36","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nchembio.2436","volume":"13","author":"JS Piotrowski","year":"2017","unstructured":"Piotrowski, J. S. et al. Functional annotation of chemical libraries across diverse biological processes. Nat. Chem. Biol. 13, 982\u2013993 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"31308_CR37","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1128\/MCB.15.11.5879","volume":"15","author":"R Egner","year":"1995","unstructured":"Egner, R., Mah\u00e9, Y., Pandjaitan, R. & Kuchler, K. Endocytosis and vacuolar degradation of the plasma membrane-localized Pdr5 ATP-binding cassette multidrug transporter in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 5879\u20135887 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"31308_CR38","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/EC.05153-11","volume":"10","author":"AE Piispanen","year":"2011","unstructured":"Piispanen, A. E. et al. Roles of Ras1 membrane localization during Candida albicans hyphal growth and farnesol response. Eukaryot. Cell 10, 1473\u20131484 (2011).","journal-title":"Eukaryot. Cell"},{"key":"31308_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nchembio.1821","volume":"11","author":"SA Davis","year":"2015","unstructured":"Davis, S. A. et al. Nontoxic antimicrobials that evade drug resistance. Nat. Chem. Biol. 11, 481\u2013487 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"31308_CR40","doi-asserted-by":"publisher","first-page":"8405","DOI":"10.1074\/jbc.M112.425769","volume":"288","author":"\u00c1 Cuesta-Marb\u00e1n","year":"2013","unstructured":"Cuesta-Marb\u00e1n, \u00c1. et al. Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast. J. Biol. Chem. 288, 8405\u20138418 (2013).","journal-title":"J. Biol. Chem."},{"key":"31308_CR41","doi-asserted-by":"crossref","unstructured":"Kim, G. H., Rosiana, S., Kirienko, N. v. & Shapiro, R. S. A. Simple nematode infection model for studying Candida albicans pathogenesis. Curr. Protoc. Microbiol. 59, e114 (2020).","DOI":"10.1002\/cpmc.114"},{"key":"31308_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nrmicro2636","volume":"9","author":"PE Sudbery","year":"2011","unstructured":"Sudbery, P. E. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9, 737\u2013748 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"31308_CR43","first-page":"1","volume":"6","author":"TR Omeara","year":"2015","unstructured":"Omeara, T. R. et al. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat. Commun. 6, 1\u201310 (2015).","journal-title":"Nat. Commun."},{"key":"31308_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1574-6968.2002.tb11330.x","volume":"214","author":"G Ramage","year":"2002","unstructured":"Ramage, G., Vande-Walle, K., Lopez-Ribot, J. L. & Wickes, B. L. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 214, 95\u2013100 (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"31308_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nrmicro2475","volume":"9","author":"JS Finkel","year":"2011","unstructured":"Finkel, J. S. & Mitchell, A. P. Genetic control of Candida albicans biofilm development. Nat. Rev. Microbiol. 9, 109\u2013118 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"31308_CR46","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1128\/AAC.39.9.2128","volume":"39","author":"SP Hawser","year":"1995","unstructured":"Hawser, S. P. & Douglas, L. J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39, 2128\u20132131 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR47","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","volume":"45","author":"G Ramage","year":"2001","unstructured":"Ramage, G., Vande Walle, K., Wickes, B. L. & L\u00f3pez-Ribot, J. L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45, 2475\u20132479 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR48","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1128\/IAI.72.10.6023-6031.2004","volume":"72","author":"D Andes","year":"2004","unstructured":"Andes, D. et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72, 6023\u20136031 (2004).","journal-title":"Infect. Immun."},{"key":"31308_CR49","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray, K. C. et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. USA 109, 2234\u20132239 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"31308_CR50","doi-asserted-by":"publisher","first-page":"e1001692","DOI":"10.1371\/journal.pbio.1001692","volume":"11","author":"BM Vincent","year":"2013","unstructured":"Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L. & Lindquist, S. Fitness trade-offs restrict the evolution of resistance to amphotericin B. PLoS Biol. 11, e1001692 (2013).","journal-title":"PLoS Biol."},{"key":"31308_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"31308_CR52","first-page":"1168","volume":"328","author":"T Schneider","year":"2010","unstructured":"Schneider, T. et al. Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science (1979) 328, 1168\u20131172 (2010).","journal-title":"Science (1979)"},{"key":"31308_CR53","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/JB.00011-12","volume":"194","author":"J Pogliano","year":"2012","unstructured":"Pogliano, J., Pogliano, N. & Silverman, J. A. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J. Bacteriol. 194, 4494\u20134504 (2012).","journal-title":"J. Bacteriol."},{"key":"31308_CR54","doi-asserted-by":"publisher","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","volume":"6","author":"SL LaFayette","year":"2010","unstructured":"LaFayette, S. L. et al. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 6, e1001069 (2010).","journal-title":"PLoS Pathog."},{"key":"31308_CR55","doi-asserted-by":"publisher","first-page":"e1003390","DOI":"10.1371\/journal.pgen.1003390","volume":"9","author":"JA Hill","year":"2013","unstructured":"Hill, J. A., Ammar, R., Torti, D., Nislow, C. & Cowen, L. E. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. PLoS Genet. 9, e1003390 (2013).","journal-title":"PLoS Genet."},{"key":"31308_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a004762","volume":"3","author":"JT Hannich","year":"2011","unstructured":"Hannich, J. T., Umebayashi, K. & Riezman, H. Distribution and functions of sterols and sphingolipids. Cold Spring Harb. Perspect. Biol. 3, 1\u201314 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"31308_CR57","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.1021\/bi971167g","volume":"36","author":"SN Ahmed","year":"1997","unstructured":"Ahmed, S. N., Brown, D. A. & London, E. On the origin of sphingolipid\/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes. Biochemistry 36, 10944\u201310953 (1997).","journal-title":"Biochemistry"},{"key":"31308_CR58","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1529\/biophysj.106.088427","volume":"92","author":"J Aittoniemi","year":"2007","unstructured":"Aittoniemi, J., Niemel\u00e4, P. S., Hyv\u00f6nen, M. T., Karttunen, M. & Vattulainen, I. Insight into the putative specific interactions between cholesterol, sphingomyelin, and palmitoyl-oleoyl phosphatidylcholine. Biophys. J. 92, 1125\u20131137 (2007).","journal-title":"Biophys. J."},{"key":"31308_CR59","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1128\/MCB.21.19.6395-6405.2001","volume":"21","author":"\u00c5 Vik","year":"2001","unstructured":"Vik, \u00c5. & Rine, J. Upc2p and Ecm22p, dual regulators of sterol biosynthesis in Saccharomyces cerevisiae. Mol. Cell. Biol. 21, 6395\u20136405 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"31308_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06944-1","volume":"9","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. Candida albicans gains azole resistance by altering sphingolipid composition. Nat. Commun. 9, 1\u201314 (2018).","journal-title":"Nat. Commun."},{"key":"31308_CR61","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jbior.2018.08.001","volume":"70","author":"J Newton","year":"2018","unstructured":"Newton, J., Milstien, S. & Spiegel, S. Niemann-Pick type C disease: the atypical sphingolipidosis. Adv. Biol. Regul. 70, 82\u201388 (2018).","journal-title":"Adv. Biol. Regul."},{"key":"31308_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/tra.12015","volume":"14","author":"X Du","year":"2013","unstructured":"Du, X., Kazim, A. S., Dawes, I. W., Brown, A. J. & Yang, H. The AAA ATPase VPS4\/SKD1 regulates endosomal cholesterol trafficking independently of ESCRT-III. Traffic 14, 107\u2013119 (2013).","journal-title":"Traffic"},{"key":"31308_CR63","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1242\/jcs.02993","volume":"119","author":"Y Ohsaki","year":"2006","unstructured":"Ohsaki, Y. et al. Cholesterol depletion facilitates ubiquitylation of NPC1 and its association with SKD1\/Vps4. J. Cell Sci. 119, 2643\u20132653 (2006).","journal-title":"J. Cell Sci."},{"key":"31308_CR64","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2019.08.038","volume":"179","author":"MB Winkler","year":"2019","unstructured":"Winkler, M. B. et al. Structural insight into eukaryotic sterol transport through Niemann-Pick Type C proteins. Cell 179, 485\u2013497.e18 (2019).","journal-title":"Cell"},{"key":"31308_CR65","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.bbalip.2019.06.002","volume":"1864","author":"MK Bennett","year":"2019","unstructured":"Bennett, M. K., Wallington-Beddoe, C. T. & Pitson, S. M. Sphingolipids and the unfolded protein response. Biochim. Biophys. Acta - Mol. Cell Biol. Lipids 1864, 1483\u20131494 (2019).","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids"},{"key":"31308_CR66","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1046\/j.1365-2958.2003.03495.x","volume":"48","author":"D Sanglard","year":"2003","unstructured":"Sanglard, D., Ischer, F., Marchetti, O., Entenza, J. & Bille, J. Calcineurin A of Candida albicans: Involvement in antifungal tolerance, cell morphogenesis and virulence. Mol. Microbiol. 48, 959\u2013976 (2003).","journal-title":"Mol. Microbiol."},{"key":"31308_CR67","doi-asserted-by":"crossref","unstructured":"Jia, X. M. et al. RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans. Cell. Mol. Life Sci. 66, 122\u2013134 (2009).","DOI":"10.1007\/s00018-008-8409-3"},{"key":"31308_CR68","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.21769\/BioProtoc.252","volume":"2","author":"J Xie","year":"2012","unstructured":"Xie, J., Singh-Babak, S. & Cowen, L. Minimum inhibitory concentration (MIC) assay for antifungal drugs. Bio-Protocol 2, e252 (2012).","journal-title":"Bio-Protocol"},{"key":"31308_CR69","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1128\/AAC.44.8.2081-2085.2000","volume":"44","author":"BA Arthington-Skaggs","year":"2000","unstructured":"Arthington-Skaggs, B. A., Warnock, D. W. & Morrison, C. J. Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 44, 2081\u20132085 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR70","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nprot.2017.005","volume":"12","author":"C M\u00fcller","year":"2017","unstructured":"M\u00fcller, C., Binder, U., Bracher, F. & Giera, M. Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography\u2013mass spectrometry. Nat. Protoc. 12, 947\u2013963 (2017).","journal-title":"Nat. Protoc."},{"key":"31308_CR71","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fmicb.2016.00501","volume":"7","author":"A Singh","year":"2016","unstructured":"Singh, A. & del Poeta, M. Sphingolipidomics: an important mechanistic tool for studying fungal pathogens. Front. Microbiol. 7, 501 (2016).","journal-title":"Front. Microbiol."},{"key":"31308_CR72","doi-asserted-by":"publisher","first-page":"349","DOI":"10.7164\/antibiotics.48.349","volume":"48","author":"SM Mandala","year":"1995","unstructured":"Mandala, S. M. et al. The discovery of Australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis producing organism, fermentation, isolation, and biological activity. J. Antibiot. 48, 349\u2013356 (1995).","journal-title":"J. Antibiot."},{"key":"31308_CR73","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/y59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"31308_CR74","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1042\/bj1950301","volume":"195","author":"NG Clarke","year":"1981","unstructured":"Clarke, N. G. & Dawson, R. M. Alkaline O leads to N-transacylation. A new method for the quantitative deacylation of phospholipids. Biochem. J. 195, 301\u2013306 (1981).","journal-title":"Biochem. J."},{"key":"31308_CR75","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0076-6879(03)75025-3","volume":"375","author":"RD Phair","year":"2003","unstructured":"Phair, R. D., Gorski, S. A. & Misteli, T. Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy. Methods Enzymol. 375, 393\u2013414 (2003).","journal-title":"Methods Enzymol."},{"key":"31308_CR76","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/tra.12008","volume":"13","author":"M Kang","year":"2012","unstructured":"Kang, M., Day, C. A., Kenworthy, A. K. & DiBenedetto, E. Simplified equation to extract diffusion coefficients from confocal FRAP data. Traffic 13, 1589 (2012).","journal-title":"Traffic"},{"key":"31308_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0304-4157(00)00009-5","volume":"1508","author":"H Heerklotz","year":"2000","unstructured":"Heerklotz, H. & Seelig, J. Titration calorimetry of surfactant-membrane partitioning and membrane solubilization. Biochim. Biophys. Acta - Biomembr. 1508, 69\u201385 (2000).","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"31308_CR78","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"31308_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"31308_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"31308_CR81","doi-asserted-by":"publisher","first-page":"e1002257","DOI":"10.1371\/journal.ppat.1002257","volume":"7","author":"N Robbins","year":"2011","unstructured":"Robbins, N. et al. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 7, e1002257 (2011).","journal-title":"PLoS Pathog."},{"key":"31308_CR82","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.01397-07","volume":"52","author":"P Uppuluri","year":"2008","unstructured":"Uppuluri, P., Nett, J., Heitman, J. & Andes, D. Synergistic effect of calcineurin inhibitors and fluconazole against Candida albicans biofilms. Antimicrob. Agents Chemother. 52, 1127\u20131132 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"31308_CR83","first-page":"e58068","volume":"2018","author":"QL Anderson","year":"2018","unstructured":"Anderson, Q. L., Revtovich, A. V. & Kirienko, N. V. A high-throughput, high-content, liquid-based C. elegans pathosystem. JoVE (J. Visualized Exp.) 2018, e58068 (2018).","journal-title":"JoVE (J. Visualized Exp.)"},{"key":"31308_CR84","doi-asserted-by":"publisher","first-page":"0168","DOI":"10.1371\/journal.ppat.0030018","volume":"3","author":"J Breger","year":"2007","unstructured":"Breger, J. et al. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3, 0168\u20130178 (2007).","journal-title":"PLoS Pathog."},{"key":"31308_CR85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/antibiotics11010072","volume":"11","author":"L Mena","year":"2022","unstructured":"Mena, L. et al. Two new compounds containing pyridinone or triazine heterocycles have antifungal properties against Candida albicans. Antibiotics 11, 72 (2022).","journal-title":"Antibiotics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31308-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31308-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T17:51:27Z","timestamp":1669312287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31308-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31308"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31308-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.E.C. and L.W. are co-founders of and shareholders in Bright Angel Therapeutics, a platform company for development of novel antifungal therapeutics. M.D.P. is a co-Founder and chief scientific officer (CSO) of MicroRid Technologies Inc. M.D.B. is a (co)-Founder, consultant, and shareholder for REVOLUTION Medicines, Ambys Medicines, Sfunga Therapeutics, Cystetic Medicines, and Kinesid Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3634"}}